Latest News

Radiotherapy-Induced Malfunction in Cardio Implantable Electronic Devices

Radiotherapy-Induced Malfunction in Cardio Implantable Electronic Devices

Whenever feasible, the use on non-neutron-producing radiotherapy is recommended.

Filgrastim Biosimilar Appears Equally Safe, Effective for Breast Cancer

Filgrastim Biosimilar Appears Equally Safe, Effective for Breast Cancer

Filgrastim are similar with no clinically meaningful differences in efficacy or safety for the prevention of severe neutropenia.

S-1 Plus Sorafenib May Be Safe, Effective for Renal Cell Carcinoma

S-1 Plus Sorafenib May Be Safe, Effective for Renal Cell Carcinoma

Combination therapy with S-1 plus sorafenib is effective and tolerable as treatment for patients with metastatic renal cell carcinoma.

Understanding How Demographics Relate to Breast Cancer Survival

Understanding How Demographics Relate to Breast Cancer Survival

Increased overall mortality in African American women with breast cancer was linked to clinical and socioeconomic factors.

21-Gene Assay Associated with Significant Change in Treatment Decisions

21-Gene Assay Associated with Significant Change in Treatment Decisions

Physicians were more likely to change treatment decisions after evaluating patients using the 21-gene Oncotype DX Assay.

Weekly Oraxol for Second-Line Treatment of Metastatic, Recurrent Gastric Cancer

Weekly Oraxol for Second-Line Treatment of Metastatic, Recurrent Gastric Cancer

Moderate efficacy and favorable toxicity levels of Oraxol as a second-line chemotherapy treatment were observed in gastric cancer.

Treatment-Related Side Effects Associated with Physical Activity in Breast Cancer Survivors

Treatment-Related Side Effects Associated with Physical Activity in Breast Cancer Survivors

Sedentary behavior was associated with increased levels of treatment-related side effects in breast cancer survivors.

Pembrolizumab vs. Chemo for Ipilimumab-Refractory Melanoma

Pembrolizumab vs. Chemo for Ipilimumab-Refractory Melanoma

Pembrolizumab has been shown to improve 6-month progression-free survival for patients with ipilimumab-refractory melanoma.

Bevacizumab with Chemo Improves Survival in Ovarian Cancer with Poor Prognosis

Bevacizumab with Chemo Improves Survival in Ovarian Cancer with Poor Prognosis

When bevacizumab was added to standard chemotherapy, patients with poor prognosis of ovarian cancer had an overall survival benefit.

In Elderly Patients with Breast Cancer, Nab-Paclitaxel Less Safe than EC/CMF

In Elderly Patients with Breast Cancer, Nab-Paclitaxel Less Safe than EC/CMF

Compared with epirubicin and 5-fluorouracil, nab-paclitaxel led to more discontinuations and toxicities in elderly breast cancer.

HOXB13 G84E Mutation Associated with Risk of Prostate Cancer

HOXB13 G84E Mutation Associated with Risk of Prostate Cancer

Rare non-conservative substitution (G84E) in HOXB13 gene found to be associated with increased risk for prostate cancer and other malignancies.

Certain Genes Associated with Colorectal Cancer Risk in Postmenopausal Women

Certain Genes Associated with Colorectal Cancer Risk in Postmenopausal Women

Genetic variants in folate-mediated one-carbon metabolism (FOCM) related to increased risk of colorectal cancer (CRC) among postmenopausal women.

Real-Life Use of Adjuvant Trastuzumab in Early Breast Cancer

Real-Life Use of Adjuvant Trastuzumab in Early Breast Cancer

Effectiveness of adjuvant trastuzumab in early-stage HER2-positive breast cancer in real life comparable to randomized clinical trials.

Chemo-Induced Ovarian Failure in Young Women with Breast Cancer

Chemo-Induced Ovarian Failure in Young Women with Breast Cancer

Ovarian toxicity may derive from acute vascular insult caused by chemotherapy in patients with breast cancer.

Anabolic Response of Essential Amino Acid Mixtures in Advanced Lung Cancer

Anabolic Response of Essential Amino Acid Mixtures in Advanced Lung Cancer

Dietary essential amino acids could have a key role in novel nutritional approaches in prevention of muscle loss in patients with cancer.

Cetuximab, Docetaxel and Cisplatin Shows Activity in Head and Neck Cancer

Cetuximab, Docetaxel and Cisplatin Shows Activity in Head and Neck Cancer

Cetuximab, docetaxel, and cisplatin (TPEx) regimen as first-line treatment for head and neck cancer showed positive activity

S-1 Plus Irinotecan Not Recommended for S-1-Refractory Gastric Cancer

S-1 Plus Irinotecan Not Recommended for S-1-Refractory Gastric Cancer

Consecutive use of S-1 plus irinotecan is not recommended as second-line treatment in advanced gastric cancer.

No Correlation Between Estrogen Metabolites, Colorectal Cancer Risk

No Correlation Between Estrogen Metabolites, Colorectal Cancer Risk

Estrogen metabolites, including estrone and estradiol, have no relationship to colorectal cancer in postmenopausal women.

Common Mutations Associated with Increased Risk for Pancreatic Cancer

Common Mutations Associated with Increased Risk for Pancreatic Cancer

Common mutations were linked to a higher susceptibility to developing pancreatic cancer.

Remote Tailored Interventions Increased Colonoscopy Screening Despite Cost Barriers

Remote Tailored Interventions Increased Colonoscopy Screening Despite Cost Barriers

Remote tailored intervention (TeleCARE) was associated with increased colonoscopy uptake among at-risk relatives for colorectal cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs